Cargando…

Renal Effects of Levosimendan: A Consensus Report

Renal dysfunction is common in clinical settings in which cardiac function is compromised such as heart failure, cardiac surgery or sepsis, and is associated with high morbidity and mortality. Levosimendan is a calcium sensitizer and potassium channel opener used in the treatment of acute heart fail...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yilmaz, Mehmet B., Grossini, Elena, Silva Cardoso, José C., Édes, István, Fedele, Francesco, Pollesello, Piero, Kivikko, Matti, Harjola, Veli-Pekka, Hasslacher, Julia, Mebazaa, Alexandre, Morelli, Andrea, le Noble, Jos, Oldner, Anders, Oulego Erroz, Ignacio, Parissis, John T., Parkhomenko, Alexander, Poelzl, Gerhard, Rehberg, Sebastian, Ricksten, Sven-Erik, Rodríguez Fernández, Luís M., Salmenperä, Markku, Singer, Mervyn, Treskatsch, Sascha, Vrtovec, Bojan, Wikström, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830192/ https://www.ncbi.nlm.nih.gov/pubmed/23929366 http://dx.doi.org/10.1007/s10557-013-6485-6

Ejemplares similares

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020)

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020)

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
por: Bouchez, S., et al.
Publicado: (2018)

Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
por: Agostoni, Piergiuseppe, et al.
Publicado: (2019)

Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)

Levosimendan: current data, clinical use and future development
por: Nieminen, M S, et al.
Publicado: (2013)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients
por: Grossini, Elena, et al.
Publicado: (2020)

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period
por: Pölzl, Gerhard, et al.
Publicado: (2018)

Levosimendan in Europe and China: An Appraisal of Evidence and Context
por: Kong, Xiangqing, et al.
Publicado: (2021)

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
por: Levijoki, Jouko, et al.
Publicado: (2022)

Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?
por: Pollesello, Piero, et al.
Publicado: (2019)

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Levosimendan Inhibits Peroxidation in Hepatocytes by Modulating Apoptosis/Autophagy Interplay
por: Grossini, Elena, et al.
Publicado: (2015)

Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
por: Herpain, Antoine, et al.
Publicado: (2019)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
por: Nieminen, Markku S., et al.
Publicado: (2017)

Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety
por: Girardis, M., et al.
Publicado: (2022)

Levosimendan‐induced venodilation is mediated by opening of potassium channels
por: Burkhoff, Daniel, et al.
Publicado: (2021)

The effects of levosimendan on myocardial oxygen consumption and coronary blood flow early after coronary artery bypass grafting
por: Lilleberg, J, et al.
Publicado: (2002)

Interaction between renal function and the effect of levosimendan on long-term mortality of patients with low-output heart failure
por: Cleland, J, et al.
Publicado: (2003)

Use of Levosimendan in Patients with Advanced Heart Failure: An Update
por: Masarone, Daniele, et al.
Publicado: (2022)

Rescue Treatment with Terlipressin for Persistent Pulmonary Hypertension and Refractory Shock in a Preterm Infant
por: Oulego-Erroz, Ignacio, et al.
Publicado: (2020)

Hemodynamic effects of levosimendan after surgery in LPS pretreated rabbits
por: Faivre, V, et al.
Publicado: (2003)

In vivo and in vitro evidence for pleiotropic effects of levosimendan in the intensive care setting
por: Yilmaz, Mehmet Birhan, et al.
Publicado: (2011)

Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta‐analysis of randomized trials
por: Silvetti, Simona, et al.
Publicado: (2017)

Influence of timing of Levosimendan administration on outcomes in cardiac surgery
por: Schiefenhövel, Fridtjof, et al.
Publicado: (2023)

Levosimendan in acute and advanced heart failure: still some chapters to be written
por: Pölzl, Gerhard
Publicado: (2018)

Systemic and regional effects of levosimendan and arginine–vaopressine in endotoxin-treated rabbits
por: Kaskos, H, et al.
Publicado: (2004)

Early assessment of lung aeration using an ultrasound score as a biomarker of developing bronchopulmonary dysplasia: a prospective observational study
por: Oulego-Erroz, Ignacio, et al.
Publicado: (2020)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan
por: Fedele, Francesco, et al.
Publicado: (2017)

Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study
por: Kivikko, Matti, et al.
Publicado: (2015)

Effects of levosimendan on renal blood flow and glomerular filtration in patients with acute kidney injury after cardiac surgery: a double blind, randomized placebo-controlled study
por: Tholén, Maria, et al.
Publicado: (2021)

Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper
por: Cholley, Bernard, et al.
Publicado: (2019)

Ultrasound-guided supraclavicular cannulation of the brachiocephalic vein may reduce central line–associated bloodstream infection in preterm infants
por: Oulego-Erroz, Ignacio, et al.
Publicado: (2020)

Early administration of levosimendan is associated with improved kidney function after cardiac surgery – a retrospective analysis
por: Balzer, Felix, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r8kr2jr44khq5892qpmp273ku7